/

Società

iV

Non verificato

iVeena Delivery Systems, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaOtticaSalute

7 comunicati stampa

Guarda tutti i comunicati

22/07/2026

Industria

Igiene alimentare

Salute

Medicina - Varie

Farmaceutica

Ottica

Biotecnologia

iVeena Delivery Systems Announces Positive End-of-Phase 1 FDA Meeting for IVMED-85

Fonte

iVeena Delivery Systems, Inc.

Emittente

1.00

0

17/07/2026

Biotecnologia

Salute

Farmaceutica

Ottica

Medicina - Varie

Industria

iVeena Delivery Systems Announces Successful Completion of Phase 1 Clinical Study of IVMED-85

Fonte

iVeena Delivery Systems, Inc.

Emittente

1.00

0

11/02/2026

Industria

Salute

Medicina - Varie

Sanità

Farmaceutica

Ottica

Biotecnologia

iVeena Delivery Systems Announces First Patient Dosed in Phase 1 Study of IVMED-85 in Healthy Adult Volunteers

Fonte

iVeena Delivery Systems, Inc.

Emittente

1.00

0

04/02/2026

Mercato del lavoro

Biotecnologia

Farmaceutica

Ottica

Salute

iVeena Delivery Systems Announces Strategic Leadership Promotions to Accelerate Growth and Scientific Innovation

Fonte

iVeena Delivery Systems, Inc.

Emittente

1.00

0

18/09/2025

Igiene alimentare

Salute

Medicina - Varie

Farmaceutica

Ottica

Biotecnologia

Mercato del lavoro

Industria

iVeena Awarded $2 Million National Eye Institute Grant to Advance Novel Therapy for Pediatric Myopia

Fonte

iVeena Delivery Systems, Inc.

Emittente

1.00

0

29/05/2025

Igiene alimentare

Salute

Medicina - Varie

Farmaceutica

Ottica

Biotecnologia

Industria

iVeena Announces IND Submission to the U.S. FDA for a Phase 2 Clinical Trial for Pediatric Myopia

Fonte

iVeena Delivery Systems, Inc.

Emittente

1.00

0

05/02/2025

Biotecnologia

Farmaceutica

Ottica

Salute

Mercato del lavoro

Industria

iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia

Fonte

iVeena Delivery Systems, Inc.

Emittente

1.00

0

Seguaci

0

Compatibilità

0